Daniel N. Swisher JR - 26 Oct 2023 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)

Role
Director
Signature
/s/ Matthew Gosling, Attorney-in-Fact for Daniel Swisher
Issuer symbol
PTGX
Transactions as of
26 Oct 2023
Transactions value $
$0
Form type
4
Filing time
30 Oct 2023, 16:31:33
Previous filing
04 Oct 2023
Next filing
03 Nov 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTGX Stock Option (right to buy) Award $0 +45K $0.00 45K 26 Oct 2023 Common Stock 45K $14.21 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest in 36 equal monthly installments following October 26, 2023, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.